DocMorris

DocMorris is the principal consumer-facing brand of DocMorris AG, the Swiss-based digital pharmacy and health-services group formerly known as Zur Rose Group. The business originated in 1993 in Switzerland, when board chairman Walter Oberhänsli and a group of physicians established Zur Rose as a pharmaceutical wholesaler serving self-dispensing doctors. Its original name came from the Zur Rose house in Steckborn, where the company opened its first stationary pharmacy and supplied medicines to doctors in the surrounding area. The company moved its headquarters from Steckborn to Frauenfeld in 1999. The group expanded through acquisitions in pharmaceutical distribution, pharmacy software, telemedicine and online commerce. Its most important consumer-brand step was the acquisition of DocMorris in 2012. DocMorris had become one of Europe's largest online pharmacies and subsequently developed into the group's best-known commercial identity, particularly in Germany. Other acquisitions included Ogera, Helvepharm, Eurapon Pharmahandel, Promofarma and apo-rot, as well as the healthcare technology companies BlueCare and TeleClinic. The group also acquired medpex, a major German online pharmacy, in 2019. DocMorris operates beyond the narrow model of an internet pharmacy. Its activities include the online sale and fulfilment of prescription and non-prescription medicines, health and personal-care products, a marketplace model, pharmacy-related logistics, telemedicine and digital health infrastructure. Associated brands and platforms have included medpex, TeleClinic, eHealth-Tec, PromoFarma and DoctiPharma. The portfolio has changed over time as the group consolidated operations and retired or integrated individual brands. The company entered the public markets through an initial public offering on the SIX Swiss Exchange in July 2017. In Switzerland, it also operated a limited number of shop-in-shop locations in cooperation with Migros. In 2022, the medpex operation was integrated at the group's Heerlen site, while logistics capacity there was more than doubled. At the same time, the Bremen logistics site was closed and the Eurapon brand was discontinued. A major corporate reorganization followed the sale of the group's Swiss Zur Rose business to Migros subsidiary Medbase in May 2023. After the transaction, Zur Rose Group AG changed its legal name to DocMorris AG and changed its SIX trading symbol from ROSE to DOCM. The rebranding aligned the listed company with its most recognized customer brand. As reported for 2023, the group had more than 10 million active customers. Its business remains concentrated on digital pharmacy and health-related services, with Germany as its most prominent market and additional operations across several European countries.

DocMorris traces its corporate history to Zur Rose, founded in 1993 in Switzerland by Walter Oberhänsli and a group of physicians. The initial business was a wholesale supplier for self-dispensing doctors. Its first stationary pharmacy operated from the Zur Rose house in Steckborn, and the company relocated to Frauenfeld in 1999. The early business therefore combined pharmacy operations with professional pharmaceutical distribution rather than beginning as a purely consumer internet retailer. During the 2000s, Zur Rose expanded its pharmaceutical infrastructure through acquisitions. Ogera was acquired in 2001, followed by Helvepharm in 2006. Helvepharm was later sold to Sanofi-Aventis in 2009. The group's strategic direction shifted decisively toward European online pharmacy in 2012, when it acquired DocMorris, described as Europe's largest online pharmacy at the time. The DocMorris name subsequently became the group's most visible consumer brand. Further expansion broadened the group geographically and technologically. Eurapon Pharmahandel was acquired in 2017, while Promofarma and apo-rot were acquired in 2018. The group added medpex in 2019, strengthening its position in Germany, and acquired TeleClinic in 2020, adding a telemedicine capability. BlueCare, acquired in 2015, provided healthcare software expertise. These transactions supported a model that combined online pharmacy, logistics, software, digital consultations and health-product commerce. Zur Rose Group completed its initial public offering on the SIX Swiss Exchange on 6 July 2017. In Switzerland, the group also developed a limited shop-in-shop presence with Migros, the country's largest retailer. The business continued to adjust its operating footprint as online pharmacy activities were consolidated. In 2022, medpex was integrated at the Heerlen site and capacity there was more than doubled. The Bremen logistics facility was closed, and the Eurapon brand was discontinued. In May 2023, the Swiss Zur Rose business was sold to Medbase, a Migros subsidiary. Following that transaction, Zur Rose Group AG adopted the name DocMorris AG and changed its SIX trading symbol from ROSE to DOCM. The change made the group's corporate identity consistent with the brand that had become most strongly associated with its European online-pharmacy activities. DocMorris now represents a digital health platform whose principal activities include e-commerce pharmacy, medicine fulfilment, health-product retail, marketplace services and selected professional and telemedicine offerings. The company reported more than 10 million active customers in 2023 and operates across Germany, the Netherlands, Spain, France and Switzerland.

• 2023

  Corporate rebranding to DocMorris AG

  [1]DocMorrisen.wikipedia.org

  After selling the Swiss Zur Rose business to Medbase, the group changes its name to DocMorris AG and its SIX ticker from ROSE to DOCM.

• 2022

  Operational consolidation

  [1]DocMorrisen.wikipedia.org

  Medpex is integrated at Heerlen, the site's capacity is expanded, the Bremen logistics site is closed and Eurapon is discontinued as a brand.

• 2019

  Medpex acquisition

  [1]DocMorrisen.wikipedia.org

  The group acquires medpex, strengthening its German online-pharmacy portfolio.

• 2017

  Initial public offering

  [1]DocMorrisen.wikipedia.org

  Zur Rose Group lists its shares on the SIX Swiss Exchange on 6 July.

• 2012

  Acquisition of DocMorris

  [1]DocMorrisen.wikipedia.org

  Zur Rose acquires the major European online pharmacy DocMorris, establishing the brand as the group's leading consumer identity.

• 1999

  Headquarters move to Frauenfeld

  [1]DocMorrisen.wikipedia.org

  The company relocates from Steckborn to Frauenfeld, which becomes its long-term headquarters.

• 1993

  Zur Rose is founded in Switzerland

  [1]DocMorrisen.wikipedia.org

  Walter Oberhänsli and a group of physicians establish the business as a pharmaceutical wholesaler serving self-dispensing doctors.

A large European digital pharmacy and integrated health-services platform combining online medicine retail, pharmacy fulfilment, health-product commerce, marketplace capabilities and selected telemedicine services.

• Online pharmacy

  DocMorris online pharmacy

  The core consumer proposition is an online pharmacy serving customers with prescription and non-prescription medicines, pharmacy advice and home delivery. DocMorris is particularly associated with the German market and has become the most recognizable customer brand of the wider DocMorris group.

• Health e-commerce

  Health and personal-care marketplace

  The group's digital commerce activities extend beyond medicines to health products, dietary supplements, beauty and personal-care goods, medical products and other pharmacy-related merchandise. Marketplace capabilities allow a broader range of health and wellness products to be presented through its online ecosystem.

• Telemedicine · 2020

  TeleClinic

  TeleClinic is the group's telemedicine-related platform, acquired in 2020. It supports the expansion of DocMorris from online medicine retail into digital consultations and connected healthcare services.

• Online pharmacy

  medpex

  Medpex was a major German online-pharmacy brand acquired by the group in 2019. Its operations were integrated at the Heerlen location in 2022, making it part of the group's consolidated logistics and operating model.

• Digital health technology

  eHealth-Tec

  eHealth-Tec is associated with the group's digital-health and healthcare-technology activities, complementing the pharmacy retail business with infrastructure and professional health-service capabilities.

• 2023

  Adopt the DocMorris corporate identityStrategy

  Background

  The sale of the Swiss Zur Rose business changed the structure and geographic composition of the listed group.

  Action taken

  Zur Rose Group AG was renamed DocMorris AG and its SIX ticker changed from ROSE to DOCM.

  Aftermath

  The listed company aligned its corporate name with its best-known consumer brand.

  Source

• 2022

  Consolidate German pharmacy operationsStrategy

  Background

  The group pursued greater operating efficiency across its German online-pharmacy brands and logistics network.

  Action taken

  Medpex was integrated at Heerlen, capacity was expanded, the Bremen logistics site was closed and the Eurapon brand was discontinued.

  Aftermath

  The group reduced brand and facility complexity while concentrating operations at a larger logistics site.

  Source

• 2017

  List on the SIX Swiss ExchangeOther

  Background

  The expanding pharmacy group required a public-market structure to support its development.

  Action taken

  Zur Rose Group completed an initial public offering on 6 July 2017.

  Aftermath

  The company became a publicly traded European pharmacy and digital-health group.

  Source

• 2012

  Acquire DocMorrisM&A

  Background

  Zur Rose sought to expand from its Swiss pharmaceutical-distribution base into European online pharmacy.

  Action taken

  The group acquired DocMorris, which became its leading consumer-facing pharmacy brand.

  Aftermath

  The acquisition established the foundation for the group's later identity and growth as a digital pharmacy operator.

  Source

1. 1DocMorrisen.wikipedia.org